Data as of:
Price 02-03-26 16:00 ET,
Balance Sheet 2025-09-30,
Income Statement 2025-09-30,
Cash Flow 2025-09-30
Indicators
Dividend indicators
Value
Date
Pays Dividend
No
2-1-2026
Income indicators
Value
Date
EBITDA Positive
No
2-1-2026
Net Income Positive
No
2-1-2026
Avg CA Burn (Annual %)
-16.64%
2-1-2026
Avg CA Burn (Quarterly %)
1.51%
2-1-2026
Shares Outstanding Changes
Date
Shares Outstanding
Delta
2025-11-10
27,148,482
+108,092
2025-09-18
27,040,390
-10
2025-08-12
27,040,400
+153,200
Short Interest Changes
Latest short interest:
771,568 shares
(2.87% of float)
| Days to cover: 4.06
Date
Short Interest
Delta
Δ %
2026-02-03
771,568 shares
+0
+0.00%
2026-02-02
771,568 shares
+0
+0.00%
2026-01-30
771,568 shares
None
—
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
Date
Volume
Shares Outstanding
Volume / Shares
Price
No interesting volume events
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.